Intrinsic Value of S&P & Nasdaq Contact Us

Owlet, Inc. OWLT NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.00
+253.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Owlet, Inc. (OWLT) has a negative trailing P/E of -73.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 22.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.36%, forward earnings yield 4.42%. PEG 0.07 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (94/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.07); analyst target implies upside (+253.4%).
  • Forward P/E 22.6 — analysts expect a return to profitability with estimated EPS of $0.25 for FY2028.
  • PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -1.36% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.42% as earnings recover.
  • Analyst consensus target $20.00 (+253.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 50/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
94/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — OWLT

Valuation Multiples
P/E (TTM)-73.3
Forward P/E22.6
PEG Ratio0.07
Forward PEG0.07
P/B Ratio79.45
P/S Ratio0.86
EV/EBITDA-8.7
Per Share Data
EPS (TTM)$-0.07
Forward EPS (Est.)$0.25
Book Value / Share$0.06
Revenue / Share$0.19
FCF / Share$-0.02
Yields & Fair Value
Earnings Yield-1.36%
Forward Earnings Yield4.42%
Dividend Yield0.00%
Analyst Target$20.00 (+253.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -5.8 0.00 -9.72 2.08 -
2020 -27.8 0.36 -14.04 3.88 -
2021 -4.1 -0.03 5.33 3.88 -
2022 -0.8 0.04 -5.85 0.90 -
2023 -1.3 0.02 -1.47 0.81 -
2024 -5.4 0.07 -3.18 0.86 -
2025 -217.3 -1.28 257.26 86.16 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-23.36 $49.8M $-17.85M -35.8%
2020 $-5.12 $75.4M $-10.52M -14%
2021 $-12.47 $75.8M $-98.17M -129.5%
2022 $-9.97 $69.2M $-79.29M -114.6%
2023 $-3.98 $54.01M $-32.9M -60.9%
2024 $-0.83 $78.06M $-12.54M -16.1%
2025 $-2.24 $105.7M $-41.9M -39.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.50 $-0.84 – $-0.15 $127.36M $123.64M – $131.09M 3
2027 $-0.19 $-0.20 – $-0.18 $154.37M $152.87M – $155.86M 2
2028 $0.25 $0.08 – $0.42 $196.23M $190.5M – $201.97M 2
2029 $1.09 $1.05 – $1.13 $277.22M $269.12M – $285.32M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message